Pharmadrug Inc
Pharmadrug Inc. operates as a specialty pharmaceutical company. The company focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally derived approved drugs. It also engages in the researching and reformulating of established natural medicines; development of synthetic formulations of existing drugs fo… Read more
Market Cap & Net Worth: Pharmadrug Inc (LMLLF)
Pharmadrug Inc (PINK:LMLLF) has a market capitalization of $1.01 Million ($1.01 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #36072 globally and #11734 in its home market, demonstrating a -14.68% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pharmadrug Inc's stock price $0.01 by its total outstanding shares 108234380 (108.23 Million).
Pharmadrug Inc Market Cap History: 2017 to 2025
Pharmadrug Inc's market capitalization history from 2017 to 2025. Data shows change from $12.12 Million to $1.01 Million (-30.06% CAGR).
Pharmadrug Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pharmadrug Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
474.08x
Pharmadrug Inc's market cap is 474.08 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $2.76 Million | $610.58K | -$6.29 Million | 4.52x | N/A |
| 2020 | $6.49 Million | $683.67K | -$5.15 Million | 9.50x | N/A |
| 2021 | $3.32 Million | $7.01K | -$5.87 Million | 474.08x | N/A |
Competitor Companies of LMLLF by Market Capitalization
Companies near Pharmadrug Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Pharmadrug Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Pharmadrug Inc Historical Marketcap From 2017 to 2025
Between 2017 and today, Pharmadrug Inc's market cap moved from $12.12 Million to $ 1.01 Million, with a yearly change of -30.06%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.01 Million | -23.77% |
| 2024 | $1.32 Million | -70.60% |
| 2023 | $4.49 Million | +260.87% |
| 2022 | $1.24 Million | -62.54% |
| 2021 | $3.32 Million | -48.83% |
| 2020 | $6.49 Million | +135.29% |
| 2019 | $2.76 Million | -85.75% |
| 2018 | $19.37 Million | +59.82% |
| 2017 | $12.12 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Pharmadrug Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.01 Million USD |
| MoneyControl | $1.01 Million USD |
| MarketWatch | $1.01 Million USD |
| marketcap.company | $1.01 Million USD |
| Reuters | $1.01 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.